Dr. Kyle Reynolds, MD

Dr. Reynolds practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Reynolds' NPI, 1417334525, was assigned on April 28, 2015. Dr. Reynolds graduated from New York Medical College in 2015. Dr. Reynolds holds District of Columbia license MD048284.

Dr. Reynolds' primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Reynolds' primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Reynolds is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Reynolds to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reynolds practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Reynolds' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Reynolds is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Reynolds' licenses on file in 3 states: District of Columbia, Virginia and Maryland.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT) and heart device and aorta surgery among the conditions Dr. Reynolds treats.

CMS data shows 1,278 Medicare services from Dr. Reynolds across 19 procedure codes in 2024, for 727 Medicare patients. Medicare paid $136,626 for them.

CMS counts 727 Medicare patients who saw Dr. Reynolds in 2024. The largest group is 75 to 84, with 286 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reynolds' median patient age at 68, with 50% women.

In 2024, Dr. Reynolds wrote 43 Medicare Part D claims for 19 patients. 67% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $13,556 in total drug cost. In 2023, CMS named 33 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Reynolds for performance year 2024, reported as part of a group. Dr. Reynolds accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of leg revascularization (restoring blood flow) by Dr. Reynolds, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Reynolds in 2021. 2021 was the busiest year, with 4. The most frequent topics are Endovascular Procedures. Dr. Reynolds has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Reynolds' most frequent co-authors are Misaki Kiguchi, MBA, MD, Steven David Abramowitz, MD and Mariya Kochubey, MD.

CMS Open Payments shows 651 general payments to Dr. Reynolds from 38 drug and device companies from 2020 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 31% of the total. ShockWave Medical, Inc paid the most, $78,537.

Dr. Reynolds graduated from New York Medical College in 2015.

Dr. Reynolds is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.